1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ARCUTIS BIOTHERAPEUTICS INC
Arcutis Biotherapeutics Inc XNAS: ARQT

Arcutis Biotherapeutics Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentia...

Read More
25.31 0.39 (1.57%)
New 52W High in past week
2.3M
XNAS Volume

XNAS 31 Oct, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Arcutis Biotherapeutics Inc is on 12 Nov 2025 for the purpose of TD Cowen Immunology & Inflammation Summit See details
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Expensive Valuation
8.5 / 100
Momentum Score
Technically Bullish
73.3 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
29
1Yr Price target upside is 16%
8 analysts

31

S

6

W

2

O

2

T

SWOT Analysis

Arcutis Biotherapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..